Detailed Information on Publication Record
2006
Dexamethasone suppression test in first-episode schizophrenia
ČEŠKOVÁ, Eva, Tomáš KAŠPÁREK, Alexandra ŽOURKOVÁ and Radovan PŘIKRYLBasic information
Original name
Dexamethasone suppression test in first-episode schizophrenia
Name in Czech
Zmírnění první epizody schizofrenie DST
Name (in English)
Dexamethasone suppression test in first-episode schizophrenia
Authors
ČEŠKOVÁ, Eva (203 Czech Republic, guarantor), Tomáš KAŠPÁREK (203 Czech Republic), Alexandra ŽOURKOVÁ (203 Czech Republic) and Radovan PŘIKRYL (203 Czech Republic)
Edition
Neuroendocrinology Letters, Stockholm, Society of Integrated Sciences, 2006, 0172-780X
Other information
Language
Czech
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 0.924
RIV identification code
RIV/00216224:14110/06:00017447
Organization unit
Faculty of Medicine
UT WoS
000243034300004
Keywords in English
dexamethasone supression test (DST); cortisolemia; first-episode schizophrenia; hypothalamic-pituitary-adrenal (HPA) axis
Tags
Tags
International impact, Reviewed
Změněno: 19/6/2009 14:22, prof. MUDr. Eva Češková, CSc.
V originále
Rates of DST nonsuppression in schizophrenia including first-episode schizophrenia are influenced by the stage of illness and medication status. The impairment of feedback regulation of cortisol secretion may be related to different biopathogenetic mechanisms depending on the phase of the illness.
In English
Rates of DST nonsuppression in schizophrenia including first-episode schizophrenia are influenced by the stage of illness and medication status. The impairment of feedback regulation of cortisol secretion may be related to different biopathogenetic mechanisms depending on the phase of the illness.
Links
| MSM0021622404, plan (intention) |
|